CARDLYTICS, INC. (CDLX) Return on equity 2018–2024
CARDLYTICS, INC. (CDLX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-270.5%FY2024 · since FY2018: -102.1% → -270.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -270.5% | -170.5 pp |
| FY2023 | -99.9% | +119.9 pp |
| FY2022 | -219.9% | -201.3 pp |
| FY2021 | -18.6% | +16.6 pp |
| FY2020 | -35.3% | -23.3 pp |
| FY2019 | -12.0% | +90.1 pp |
| FY2018 | -102.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX RevenueCDLX Net incomeCDLX Net marginCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating marginCDLX Operating cash flowCDLX Free cash flowCDLX Capital expendituresCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Total liabilitiesCDLX Shareholders’ equityCDLX overview →